Burning mouth syndrome
RecruitingStudy on Clonazepam for Treating Burning Mouth Syndrome in Patients
- Disease:Burning mouth syndrome
- Substances:Clonazepam
Sweden- Participants:18–64 years · 65+ years
- Substances:Clonazepam
- Sponsor:Malmoe Universitet
Rare diseases
Investigational molecules
Locations
Bassanggatan 2, 211 19 Malmo, Sweden
Burning mouth syndrome is a key area of clinical interest, with research centred on symptom relief, pain intensity, sensory disturbance, and jaw function in affected patients.
Interest also extends to treatment preference and the relationship between perceived benefit and individual experience of therapy.
Malmoe Universitet runs clinical trials in conditions such as Burning mouth syndrome, Diabetic foot, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Sweden
SwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.